Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Eczacıbaşı İlaç PazarlamaEczacıbaşı İlaç Pazarlama
VS
Ipca Laboratories LimitedIpca Laboratories Limited
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

Levent Mahallesi, Büyükdere Caddesi, Ali Kaya Sk. No: 5, İstanbul, 34394, TR

Last Update: 28/04/2026

View Profile
Between 750 and 799
http://www.eip.com.tr
758/1000Fair

Eczacıbaşı Pharmaceuticals Marketing carries out the marketing, promotion, sales and distribution of imported and contract manufactured pharmaceuticals for mass and niche markets and health-based personal care products. Due to its growing portfolio and target audience, ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:610
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.ipca.com/
768/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eczacıbaşı İlaç Pazarlama in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incident History - Eczacıbaşı İlaç Pazarlama (X = Date, Y = Severity)

Eczacıbaşı İlaç Pazarlama cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Eczacıbaşı İlaç Pazarlama

Eczacıbaşı İlaç Pazarlama

Incidents
No explicit notable incidents reported.
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has the best AI Cybersecurity Score ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced more cyber incidents in the past ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced more cyber incidents this year ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced at least one ransomware attack ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced at least one data breach ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced at least one targeted cyberattack ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has experienced at least one vulnerability ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one holds the most compliance certifications ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one holds the fewest compliance certifications ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has the most subsidiaries ?
Between Eczacıbaşı İlaç Pazarlama company and Ipca Laboratories Limited company, which one has the largest number of employees ?
Between Eczacıbaşı İlaç Pazarlama and Ipca Laboratories Limited, which company holds both SOC 2 Type 1 certifications ?
Between Eczacıbaşı İlaç Pazarlama and Ipca Laboratories Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Eczacıbaşı İlaç Pazarlama or Ipca Laboratories Limited ?
Which company is PCI DSS compliant - Eczacıbaşı İlaç Pazarlama or Ipca Laboratories Limited ?
Between Eczacıbaşı İlaç Pazarlama and Ipca Laboratories Limited, which company complies with HIPAA regulations for healthcare data ?
Between Eczacıbaşı İlaç Pazarlama and Ipca Laboratories Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57100
SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-54998
SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-45499
SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-41106
SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-26145
SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 4.8)
CVSS3
Base Score: 4.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES